RegeneRx

RegeneRx is a publicly traded, clinical-stage biopharmaceutical company focused on the design, research, and development of novel peptides targeting diseases with unmet medical needs. RegeneRx's mission is to research and develop innovative drugs to protect and repair tissue and organ damage caused by disease, injury, or other pathological conditions.